Alpine Immune Sciences
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Alpine Immune Sciences generated cash of -$79,012,000, which is less than the previous year. Cash used in financing activities reached the amount of $165,122,000 last year. Net change in cash is therefore $30,559,000.

Cash Flow

Alpine Immune Sciences, Inc. (NASDAQ:ALPN): Cash Flow
2014 -14.44M -4.1K 41.16M
2015 -19.20M -62.44M 78.83M
2016 -26.25M 25.30M 166K
2017 -16.57M -29.80M 42.68M
2018 -28.41M 32.11M -991K
2019 -35.34M 16.76M 24.25M
2020 30.08M -72.81M 61.38M
2021 -15.24M -52.48M 100.76M
2022 -43.75M -113.34M 102.68M
2023 -79.01M -55.55M 165.12M

ALPN Cash Flow Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash at beginning of period
13.63M68.16M35.21M16.50M10.84M8.13M11.81M24.99M27.81M1.09M
Operating activities
Net income
-32.18M-57.76M-50.33M-27.94M-41.85M-36.48M-7.78M-31.46M-22.81M-15.03M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
576K597K620K578K468K388K241K143K66K86.44K
Stock-based compensation expense
10.63M9.64M6.24M4.14M3.04M0838K3.26M1.34M69.62K
Deferred income tax benefit 10.63M9.64M6.24M4.14M3.04M0838K3.26M1.34M69.62K
Changes in operating assets and liabilities:
Accounts receivable, net
225K24.60M00000000
Inventories
0000000000
Accounts payable
6.51M5.55M5.97M-491K816K1.52M66K927K65K258.25K
Cash generated by operating activities
-79.01M-43.75M-15.24M30.08M-35.34M-28.41M-16.57M-26.25M-19.20M-14.44M
Investing activities
Purchases Of Investments
-351.34M-266.98M-133.51M-101.32M-59.38M-72.86M-88.30M-75.32M-76.26M0
Investments In Property Plant And Equipment
-487K-412K-118K-802K-821K-495K-586K-106K-188K-4.1K
Acquisitions Net
0112.93M52.36M72.01M-17.58M031.13M000
Cash generated by investing activities
-55.55M-113.34M-52.48M-72.81M16.76M32.11M-29.80M25.30M-62.44M-4.1K
Financing activities
Common Stock Issued
168.54M106.71M102.66M56.25M23.59M9K37.66M20K78.77M11.86M
Payments for dividends
0000000000
Repurchases of common stock
0000000000
Repayments of term debt
00-2.4M-5M0-1M000-3.13M
Cash used in financing activities
165.12M102.68M100.76M61.38M24.25M-991K42.68M166K78.83M41.16M
Net Change In Cash
30.55M-54.53M32.94M18.70M5.66M2.71M-3.68M-788K-2.82M26.71M
Cash at end of period
44.18M13.63M68.16M35.21M16.50M10.84M8.13M24.20M24.99M27.81M
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source